Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPTp with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in pregnant women
PACTR202406478822577Phase 4Not yet recruiting
- Sponsor
- Africa Center of Excellence for Population Health and Policy
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of sulfadoxine + pyrimethamine and dihydroartemisinin + piperaquine in malaria, sponsored by Africa Center of Excellence for Population Health and Policy. Primary endpoint: Prevalence of maternal malaria at delivery. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
sulfadoxine + pyrimethaminedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202406478822577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406478822577.